Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Variable severity in autosomal dominant optic atrophy.

W G Pearce

    Ophthalmic Paediatrics and Genetics
    |February 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A summary of 20 CACNA1F mutations identified in 36 families with incomplete X-linked congenital stationary night blindness, and characterization of splice variants.

    Human genetics·2001
    Same author

    Clinical variability among patients with incomplete X-linked congenital stationary night blindness and a founder mutation in CACNA1F.

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2000
    Same author

    Histopathology and molecular basis of iridogoniodysgenesis syndrome.

    Ophthalmic genetics·1999
    Same author

    Localization of a gene for incomplete X-linked congenital stationary night blindness to the interval between DXS6849 and DXS8023 in Xp11.23.

    Human genetics·1998
    Same author

    Loss-of-function mutations in a calcium-channel alpha1-subunit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness.

    Nature genetics·1998
    Same author

    Evidence for genetic heterogeneity in X-linked congenital stationary night blindness.

    American journal of human genetics·1998
    Same journal

    Ocular growth in infant aphakia. Bilateral versus unilateral congenital cataracts.

    Ophthalmic paediatrics and genetics·1993
    Same journal

    Butterfly-shaped macular dystrophy. Longitudinal case study of two siblings.

    Ophthalmic paediatrics and genetics·1993
    Same journal

    A variant of central areolar choroidal dystrophy.

    Ophthalmic paediatrics and genetics·1993
    Same journal

    North Carolina macular dystrophy (MCDR1). A review and refined mapping to 6q14-q16.2.

    Ophthalmic paediatrics and genetics·1993
    Same journal

    To lump or to split?

    Ophthalmic paediatrics and genetics·1993
    Same journal

    Ligneous conjunctivitis. Ten years follow-up.

    Ophthalmic paediatrics and genetics·1993
    See all related articles

    Autosomal dominant optic atrophy likely stems from a single genetic cause, despite variations in onset and severity. Early-onset cases exhibit more severe vision loss compared to later-onset individuals.

    Area of Science:

    • Ophthalmology
    • Genetics
    • Neuroscience

    Background:

    • Autosomal dominant optic atrophy (ADOA) literature suggests potential congenital and post-natal genetic types.
    • Understanding ADOA's genetic basis is crucial for diagnosis and treatment.

    Observation:

    • Ocular findings in a three-member family (father, two daughters) with ADOA align with a 'congenital' type.
    • Comparison with 17 additional cases revealed a spectrum of disease severity.
    • Early or congenital onset ADOA cases presented with more severe visual impairment.

    Findings:

    • Patients with later onset ADOA experienced milder visual impairment and often had prolonged periods with minimal visual difficulties.
    • Severity of visual impairment in ADOA correlates with age of onset.

    Related Experiment Videos

  • Variation in clinical presentation is characteristic of autosomal dominant inheritance patterns.

    • Implications:

    • The observed variability supports the hypothesis of a single genetic locus for autosomal dominant optic atrophy.
    • Further research into ADOA genetics can refine diagnostic criteria and therapeutic strategies.
    • Understanding the spectrum of ADOA is vital for genetic counseling and patient management.